Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Abpro Holdings Inc. (ABPO : OTC)

• Company Description    Abpro Holdings Inc. is a biotechnology company. The company's mission is to improve the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies. Abpro Holdings Inc., formerly known as Atlantic Coastal Acquisition Corp. II, is based in WOBURN, Mass. Number of Employees: 3

• Price / Volume Information    Yesterday's Closing Price: $0.22 Daily Weekly Monthly 20 Day Moving Average: 22,980 shares Shares Outstanding: 5.90 (millions) Market Capitalization: $1.30 (millions) Beta: 0.15 52 Week High: $13.65 52 Week Low: $0.09 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 54.28% 46.74% 12 Week 50.69% 39.30% Year To Date -94.80% -95.22%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 100 Summit Drive - Burlington,MA 01803 USA ph: 339-227-5961 fax: - ir@abpro.com http://www.abpro.co

• General Corporate Information    Officers Miles Suk - Chief Executive Officer Miles Suk - Chief Financial Officer Fatih Karatas - Director Byung-Hak Yoon - Director Joanna Lord - Director Peer Information Abpro Holdings Inc. (CORR.) Abpro Holdings Inc. (RSPI) Abpro Holdings Inc. (CGXP) Abpro Holdings Inc. (BGEN) Abpro Holdings Inc. (GTBP) Abpro Holdings Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 000847202 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/12/26 Share - Related Items Shares Outstanding: 5.90 Most Recent Split Date: 11.00 (0.03:1) Beta: 0.15 Market Capitalization: $1.30 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/12/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 0.29 PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 90.43% vs. Previous Quarter: -108.16% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/26 - -6.70 12/31/25 - - 09/30/25 - - ROA 03/31/26 - 22.02 12/31/25 - -85.21 09/30/25 - -344.76 Current Ratio 03/31/26 - 0.74 12/31/25 - 0.10 09/30/25 - 0.07 Quick Ratio 03/31/26 - - 12/31/25 - 0.10 09/30/25 - 0.07 Operating Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Net Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Pre-Tax Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Book Value 03/31/26 - -0.38 12/31/25 - -3.03 09/30/25 - -5.84 Inventory Turnover 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Equity 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Capital 03/31/26 - - 12/31/25 - - 09/30/25 - -

Powered by Zacks Investment Research ©